⌘K

Login Start Free

Home/Filings/4/0001310204-25-000014

4//SEC Filing

Dickinson Andrew D 4

Accession 0001310204-25-000014

CIK 0000882095other

View on SEC.gov Company Profile

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 9:35 PM ET

Size

4.8 KB

Accession

0001310204-25-000014

Insider Transaction Report

Form 4

Period: 2025-10-15

GILEAD SCIENCES, INC.GILD

Dickinson Andrew D

Chief Financial Officer

Transactions

Sale
Common Stock
2025-10-15$118.08/sh−2,500$295,200→ 157,055 total

Footnotes (1)

[F1]The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.

Documents

1 file

4
wk-form4_1760664900.xmlPrimary
FORM 4

Issuer

GILEAD SCIENCES, INC.

CIK 0000882095

Entity typeother

Related Parties

1

filerCIK 0001310204

Filing Metadata

Form type: 4
Filed: Oct 15, 8:00 PM ET
Accepted: Oct 16, 9:35 PM ET
Size: 4.8 KB

View on SEC.gov